Clinical Trial Update: T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial of T-ACE Oil for hepatocellular carcinoma (Phase 1/Phase 2) is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• T-ACE Oil

Snippet

Sponsor: T-ACE Medical Co., Ltd | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: SUSPENDED